Release of RANTES from nasal and bronchial epithelial cells

Cell Biology and Toxicology

Volumn 13, Issue 3, 1997, Pages 205-213

  Altman, G B ^a   Altman, L C ^a,b   Luchtel, D L ^a   Jabbour, A J ^a   Baker, C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NW Asthma and Allergy Center ^*  (United States)

Author keywords

asthma; bronchial epithelium; chemokine; cytokine; dexamethasone; nasal epithelium; RANTES; rhinitis

Indexed keywords

CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONKEY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RHINITIS;

ADULT; ANIMALS; BRONCHI; CELLS, CULTURED; DEXAMETHASONE; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; MACACA NEMESTRINA; MALE; MIDDLE AGED; NASAL MUCOSA; PRECIPITIN TESTS; RANTES;

ANIMALIA; BRONCHUS; MACACA NEMESTRINA; PRIMATES;

EID: 0030905406     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007318514715     Document Type: Article

References (28)

1. Aizawa T, Sekizawa K, Aikawa T et al. Eosinophil supernatant causes hyperresponsiveness of airway smooth muscle in guinea pig trachea. Am Rev Respir Dis. 1990;142:133-7.
2. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol. 1993;150:3442-7.
3. Alam R, York J, Boyars M et al. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med. 1996;153: 1398.
4. Altman LC, Gleich GJ. Eosinophils. Immunol Allergy Clin North Am. 1990;10(2):263-71.
5. Ayars GH, Altman LC, McManus MM et al. Injurious effect of the eosinophil peroxidase-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis. 1988;40:125-31.
6. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988;138:406-12.
7. Berkman N, Robichaud A, Krishnan VL et al. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology. 1996;87:599.
8. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;343:1514-5.
9. Davies RJ, Wang JH, Trigg CJ, Devalia JL. Expression of granulocyte/macrophage-colony-stimulating factor, interleukin-8 and RANTES in the bronchial epithelium of mild asthmatics is down-regulated by inhaled beclomethasone dipropionate. Int Arch Allergy Immunol. 1995;107:428-9.
10. Ebiswa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol. 1994;153:2153-60.
11. Holgate ST, Roche WR, Church MK. The role of the eosinophil in asthma. Am Rev Respir Dis. 1991;143:S66-70.
12. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med, 1992;176:587.
13. Kenney JS, Masada MP, Eugui EM, DeLustro BM, Mulkins MA, Allison AC. Monoclonal antibodies to human recombinant interleukin 1 (IL-1)β; quantitation of IL-1β and inhibition of biological activity. J Immunol. 1987;138: 4236-42.
14. Kenney JS, Baker C, Welch MR, Altman LC. Synthesis of interleukin-1α, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol. 1994;93:1060-7.
15. Konno S, Gonokami Y, Kurokawa M et al. Cytokine concentrations in sputum of asthmatic patients. Int Arch Allergy Immunol. 1996;109:73.
16. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol. 1995;12:488-96.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680.
18. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol. 1992;89:1001.
19. Manni A, Kleimberg J, Ackerman V, Bellini A, Patalano F, Mattoli S. Inducibility of RANTES mRNA by IL-1β in human bronchial epithelial cells is associated with increased NF-kB DNA binding activity. Biochem Biophys Res Commun. 1996;220:120.
20. McManus MS, Altman LC, Koenig JQ et al. Human nasal epithelium: characterization and effects of in vitro exposure to sulfur dioxide. Exp Lung Res. 1989;15:849-65.
21. Miller D, Krangel M. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 1992;12:17-46.
22. Naclerio RM. Allergic rhinitis. N Engl J Med. 1991;325:860-9.
23. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med. 1992;176:1489-95.
24. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine. 1991;3:165-83.
25. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol. 1994;10:142-7.
26. Stellato C, Beck LA, Gorgone GA et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol. 1995;155:410-8.
27. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol. 1996;14:27.
28. Zeck-Kapp G, Kapp A. Subcellular mechanisms of eosinophil degranulation: the role of RANTES, interleukin-5 and tumor necrosis factor-α. Int Arch Allergy Immunol. 1995; 107:345.